Evidence map›Paper›PMID 35346565›Full record

ArticleAcademic radiology2022

Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients.

Vitali Koch, Leon D Gruenewald, Moritz H Albrecht, Katrin Eichler, Tatjana Gruber-Rouh, Ibrahim Yel, Leona S Alizadeh, Scherwin Mahmoudi, Jan-Erik Scholtz, Simon S Martin and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Academic radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 4 countries.

Vitali KochDivision of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Leon D GruenewaldDivision of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Moritz H AlbrechtDivision of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Katrin EichlerDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Tatjana Gruber-RouhDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Ibrahim YelDivision of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Leona S AlizadehDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Scherwin MahmoudiDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Jan-Erik ScholtzDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Simon S MartinDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Lukas LengaDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Thomas J VoglDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Nour-Eldin A Nour-EldinInstitute for Diagnostic and Interventional Radiology, Frankfurt University Hospital, Frankfurt, Germany; Department of Diagnostic and Interventional Radiology, Cairo University Hospital, Cairo, Egypt.
Florian BienenfeldDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Renate M HammerstinglDepartment of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Christiana GrafDepartment of Internal Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Christof M SommerDepartment of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Stefan E HardtDepartment of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Silvio MazziottiDepartment of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy.
Giorgio AscentiDepartment of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy.
Giovanni Antonio VersaceDepartment of Clinical and Experimental Medicine, University Hospital Messina, Messina, Italy.
Tommaso D'AngeloDepartment of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands. Electronic address: tommasodang@gmail.com.
Christian BoozDivision of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Goethe University Frankfurt · DEUniversity of Messina · ITHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess and correlate pulmonary involvement and outcome of SARS-CoV-2 pneumonia with the degree of coronary plaque burden based on the CAC-DRS classification (Coronary Artery Calcium Data and Reporting System).

methodsThis retrospective study included 142 patients with confirmed SARS-CoV-2 pneumonia (58 ± 16 years; 57 women) who underwent non-contrast CT between January 2020 and August 2021 and were followed up for 129 ± 72 days. One experienced blinded radiologist analyzed CT series for the presence and extent of calcified plaque burden according to the visual and quantitative HU-based CAC-DRS Score. Pulmonary involvement was automatically evaluated with a dedicated software prototype by another two experienced radiologists and expressed as Opacity Score.

resultsCAC-DRS Scores derived from visual and quantitative image evaluation correlated well with the Opacity Score (r=0.81, 95% CI 0.76-0.86, and r=0.83, 95% CI 0.77-0.89, respectively; p<0.0001) with higher correlation in severe than in mild stage SARS-CoV-2 pneumonia (p<0.0001). Combined, CAC-DRS and Opacity Scores revealed great potential to discriminate fatal outcomes from a mild course of disease (AUC 0.938, 95% CI 0.89-0.97), and the need for intensive care treatment (AUC 0.801, 95% CI 0.77-0.83). Visual and quantitative CAC-DRS Scores provided independent prognostic information on all-cause mortality (p=0.0016 and p<0.0001, respectively), both in univariate and multivariate analysis.

conclusionsCoronary plaque burden is strongly correlated to pulmonary involvement, adverse outcome, and death due to respiratory failure in patients with SARS-CoV-2 pneumonia, offering great potential to identify individuals at high risk.

Indexed as

Coronary Artery DiseaseCOVID-19Plaque, AtheroscleroticVascular CalcificationCalciumCoronary AngiographyCoronary VesselsFemaleHumansLungMalePredictive Value of TestsPrognosisRetrospective StudiesRisk AssessmentRisk FactorsCalciumCAC-DRS ScoreComputed TomographyCoronary Heart DiseaseCoronary Plaque BurdenSARS-CoV-2 Pneumonia

Identifiers

PMID35346565
PMCPMC8882413
OpenAlexW4214710101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.